Hrt Financial LP Ginkgo Bioworks Holdings, Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $1.16 $809,674 - $3.35 Million	2,891,693 Added 153.18%	4,779,497 $1.58 Million
Q1 2024 May 13, 2024	BUY	$1.06 - $1.67 $1.67 Million - $2.64 Million	1,579,082 Added 511.49%	1,887,804 $2.19 Million
Q4 2023 Feb 09, 2024	SELL	$1.26 - $1.79 $1.84 Million - $2.61 Million	-1,457,296 Reduced 82.52%	308,722 $521,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $2.84 Million - $4.49 Million	1,766,018 New	1,766,018 $3.2 Million
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $439,857 - $802,740	366,548 New	366,548 $487,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $331,951 - $1.7 Million	454,728 New	454,728 $1.42 Million
Q2 2022 Aug 12, 2022	SELL	$2.2 - $4.2 $16.7 Million - $31.9 Million	-7,602,543 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $21.5 Million - $66.1 Million	7,602,543 New	7,602,543 $30.6 Million
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $1.94 Million - $3.48 Million	-233,238 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $2.13 Million - $3.1 Million	233,238 New	233,238 $2.7 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.